TherapeuticsMD: Q2 Earnings Insights

TherapeuticsMD TXMD reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

TherapeuticsMD missed estimated earnings by 13.16%, reporting an EPS of $-3.44 versus an estimate of $-3.04.

Revenue was up $5.56 million from the same period last year.

Last quarter the company missed on EPS by $0.72 which was followed by a 14.01% drop in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-4	-4	-5	-5.5
EPS Actual	-4.72	-4.5	-5.5	-5.5
Revenue Estimate	17.95M	29.39M	25.87M	22.11M
Revenue Actual	19.33M	18.68M	25.41M	23.00M

To track all earnings releases for TherapeuticsMD visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.